Association of Interleukin-10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer susceptibility in Quetta, Pakistan
https://doi.org/10.21294/1814-4861-2025-24-3-76-92
Abstract
Background. Interleukin-10 (IL-10) regulates immune responses and has been linked to cancer development. Polymorphisms in the IL-10 gene, such as rs1800872 and rs1800896, may affect cancer susceptibility. No previous study has examined the association between these variants and cervical cancer in Quetta, Pakistan, which this study aims to address.
Aims. This study aimed to investigate the association between IL-10 gene polymorphisms (rs1800872 and rs1800896) and cervical cancer susceptibility among women in Quetta, Pakistan, and to determine the prevalence and risk factors contributing to cervical cancer in this population.
Material and Methods. A total of 50 patients diagnosed with cervical cancer and 50 individuals without any health issues were selected for the case-control analysis. Data was collected for retrospective analysis using a pre-designed data collection form. Demographic information and blood samples were collected from participants with explicit consent. The DNA was extracted using an organic approach, and genotyping was performed using the TETRA primer ARMS-PCR technique. The data analysis was conducted using multinomial logistic regression with a 95 % confidence interval, utilizing the SPSS software.
Results. The study demonstrated no significant association between IL-10 gene polymorphisms (rs1800872 and rs1800896) and cervical cancer among the population of Quetta City. Statistically significant relationships were found between cervical cancer and smoking, lack of exercise, menarche, and usage of oral contraceptive medications.
Conclusion. This study confirms no association between IL-10 gene polymorphisms (rs1800872 and rs1800896) and cervical cancer in Quetta. Furthermore, a lack of awareness regarding cervical cancer poses a significant obstacle to its effective care at the individual level in Pakistan.
About the Authors
N. Mohammad
Department of Zoology, Faculty of Life Sciences, Sardar Bahadur Khan Women’s University
Pakistan
Pakistan
Mohammad Nadia - M. Phil., Researcher.
Quetta, 87300
M. Khan
Department of Zoology, Faculty of Life Sciences, Sardar Bahadur Khan Women’s University
Pakistan
Pakistan
Khan Maria - M. Phil., Researcher.
Quetta, 87300
M. Maqsood
Department of Zoology, Faculty of Life Sciences, Sardar Bahadur Khan Women’s University
Pakistan
Pakistan
Maqsood Maryam - PhD (Medical Microbiology), Assistant Professor.
Quetta, 87300
A.H.K. Naseeb
Center for Nuclear Medicine and Radiotherapy (CENAR)
Pakistan
Pakistan
Hafiz Khush Naseeb Ahmed - MBBS, FCPS, Nuclear Medicine Physician, Director.
Brewery Road, Quetta, 87300
References
1. Chughtai N., Perveen K., Gillani S.R., Abbas A., Chunara R., Manji A.A., Karani S., Noorali A.A., Zakaria M., Shamsi U., Chishti U., Khan A.A., Soofi S., Pervez S., Samad Z. National cervical cancer burden estimation through systematic review and analysis of publicly available data in Pakistan. BMC Public Health. 2023; 23(1): 834. doi: 10.1186/s12889-023-15531-z.
2. Luvián-Morales J., Gutiérrez-Enríquez S.O., Granados-García V., Torres-Poveda K. Risk factors for the development of cervical cancer: analysis of the evidence. Front Oncol. 2024; 14: 1378549. doi: 10.3389/fonc.2024.1378549.
3. Idrees R., Fatima S., Abdul-Ghafar J., Raheem A., Ahmad Z. Cancer prevalence in Pakistan: meta-analysis of various published studies to determine variation in cancer figures resulting from marked population heterogeneity in different parts of the country. World J Surg Oncol. 2018; 16(1): 129. doi: 10.1186/s12957-018-1429-z.
4. Yusuf A. Cancer care in Pakistan. Jpn J Clin Oncol. 2013; 43(8): 771–75. doi: 10.1093/jjco/hyt078.
5. Batool S.A., Sajjad S., Malik H. Cervical cancer in Pakistan: A review. J Pak Med Assoc. 2017; 67(7): 1074–77.
6. Shahnaz S., Fricovsky E., Anwar R., Arain M.I. Cervical Cancer Awareness and Attitude Towards Cervical Cancer Screening and Human Papillomavirus Vaccines Among Urban Women of Karachi, Pakistan. Cureus. 2023; 15(8): e42970. doi: 10.7759/cureus.42970.
7. Guo C., Wen L., Song J.K., Zeng W.J., Dan C., Niu Y.M., Shen M. Significant association between interleukin-10 gene polymorphisms and cervical cancer risk: a meta-analysis. Oncotarget. 2018; 9(15): 12365–75. doi: 10.18632/oncotarget.24193.
8. Chiarella P., Capone P., Sisto R. Contribution of genetic polymorphisms in human health. Int J Environ Res Public Health. 2023; 20(2): 912. doi: 10.3390/ijerph20020912.
9. Pereira A.P.L., Trugilo K.P., Okuyama N.C.M., Sena M.M., Couto-Filho J.D., Watanabe M.A.E., de Oliveira K.B. IL-10 c.-592C>A (rs1800872) polymorphism is associated with cervical cancer. J Cancer Res Clin Oncol. 2020; 146(8): 1971–78. doi: 10.1007/s00432-020-03256-0.
10. Vakili M., Shirinzadeh-Dastgiri A., Ershadi R., Dastgheib S.A., Shiri A., Aghasipour M., Barahman M., Manzourolhojeh M., Aghili K., Neamatzadeh H., Akbarian E. Correlation between rs1800871, rs1800872 and rs1800896 Polymorphisms at IL-10 Gene and Lung Cancer Risk. Asian Pac J Cancer Prev. 2024; 25(1): 287–98. doi: 10.31557/APJCP.2024.25.1.287.
11. Bønløkke S., Blaakær J., Steiniche T., Iachina M. Social factors and age play a significant role in cervical cancer and advanced-stage disease among Danish women. BMC Cancer. 2024; 24(1): 259. doi: 10.1186/s12885-024-11994-4.
12. Sabeena S., Ravishankar N., Kalpana M.M. Implementation strategies of cervical cancer screening in South Asia: A systematic review. Int J Gynaecol Obstet. 2024; 166(2): 483–93. doi: 10.1002/ijgo.15366.
13. ICO/IARC Information Centre on HPV and Cancer. Pakistan: Human papillomavirus and related cancers, fact sheet 2023. ICO/IARC HPV Information Centre. [Internet]. [cited 01.08.2024]. URL: https://hpvcentre.net/statistics/reports/PAK_FS.pdf.
14. Raza S.A., Franceschi S., Pallardy S., Malik F.R., Avan B.I., Zafar A., Ali S.H., Pervez S., Serajuddaula S., Snijders P.J., van Kemenade F.J., Meijer C.J., Shershah S., Clifford G.M. Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan. Br J Cancer. 2010; 102(11): 1657–60. doi: 10.1038/sj.bjc.6605664.
15. Kousar K., Ahmad T., Naseer F., Kakar S., Anjum S. Review Article: Immune Landscape and Immunotherapy Options in Cervical Carcinoma. Cancers (Basel). 2022; 14(18): 4458. doi: 10.3390/cancers14184458.
16. Yadav R., Chauhan M.B., Yadav C., Ranga S., Ahuja P., Tanwar M., Balhara N., Kadian L., Chauhan P., Tanwar N., Ahlawat C. Awareness data on cervical cancer among females of rural and urban areas of Haryana, India. Data Brief. 2024; 53: 110168. doi: 10.1016/j.dib.2024.110168.
17. Khorrami S., Zamani H., Hasanzadeh M., Mehramiz M., Soleimani A., Zare Marzouni H., Ferns G.A., Esmaeili H., Avan A. Association of a genetic variant in Interleukin-10 gene with increased risk and inflammation associated with cervical cancer. Gene. 2022; 807: 145933. doi: 10.1016/j.gene.2021.145933.
18. Vu T.Q/C, Truong T.G., Tran Q.D., Bui The prevalence and factors related to late-stage among cervical cancer patients in Southeast Asian countries: A systematic review and meta-analysis. Indian J Gynecol Oncol. 2024; 22(1): 32.
19. Audirac-Chalifour A., Torres-Poveda K., Bahena-Román M., TéllezSosa J., Martínez-Barnetche J., Cortina-Ceballos B., López-Estrada G., Delgado-Romero K., Burguete-García A.I., Cantú D., García-Carrancá A., Madrid-Marina V. Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study. PLoS One. 2016; 11(4): e0153274. doi: 10.1371/journal.pone.0153274.
20. Rubina Mukhtar, Rubaida Mehmood, Shahida Parveen, Mukhtar Hussain, M. Arif Prevalence of cervical cancer in developing country: Pakistan. Glob J Med Res. 2015; 15(3): 2249–4618.
21. Sharma P., Pattanshetty S.M. A study on risk factors of cervical cancer among patients attending a tertiary care hospital: A case-control study. Clin Epidemiol Glob Health. 2018; 6(2): 83–87. doi: 10.1016/j.cegh.2017.10.001.
22. Datta A., Tuz Zahora F., Abdul Aziz M., Sarowar Uddin M., Ferdous M., Shalahuddin Millat M., Shahid Sarwar M., Abdul Barek M., Jafrin S., Nahar S., Safiqul Islam M. Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women. Int Immunopharmacol. 2020; 89(Pt B): 107091. doi: 10.1016/j.intimp.2020.107091.
23. Ding Q., Shi Y., Fan B., Fan Z., Ding L., Li F., Tu W., Jin X., Wang J. The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls. PLoS One. 2013; 8(2): e57246. doi: 10.1371/journal.pone.0057246.
Review
For citations:
Mohammad N., Khan M., Maqsood M., Naseeb A. Association of Interleukin-10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer susceptibility in Quetta, Pakistan. Siberian journal of oncology. 2025;24(3):76-92. https://doi.org/10.21294/1814-4861-2025-24-3-76-92
Views:
41
Email this article 
